Evidence map›Paper›PMID 40174553›Full record

ArticleEBioMedicine2025

Computational fluid dynamics of small airway disease in chronic obstructive pulmonary disease.

Yousry K Mohamady, Vincent Geudens, Charlotte De Fays, Marta Zapata, Omar Hagrass, Lucia Aversa, Marie Vermant, Xin Jin, Lynn Willems, Iwein Gyselinck and 29 more

Abstract read
In one paragraph

Article in EBioMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. The importance of mechanical forces in chronic respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Yousry K MohamadyLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: yousry.mohamady@kuleuven.be.
Vincent GeudensLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Vincent.Geudens@kuleuven.be.
Charlotte De FaysLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium; Pneumology Lab, Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium. Electronic address: charlotte.defays@saintluc.uclouvain.be.
Marta ZapataLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Marta.Zapata@kuleuven.be.
Omar HagrassDepartment of Operations Research and Financial Engineering, Princeton University, USA. Electronic address: oh2588@princeton.edu.
Lucia AversaLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Lucia.Aversa@kuleuven.be.
Marie VermantLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Marie.Vermant@kuleuven.be.
Xin JinLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Xin.Jin@kuleuven.be.
Lynn WillemsLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Lynn.Willems@kuleuven.be.
Iwein GyselinckLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: iwein.gyselinck@uzleuven.be.
Charlotte HooftLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Charlotte.Hooft@kuleuven.be.
Astrid VermautLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Astrid.Vermaut@kuleuven.be.
Hanne BeeckmansLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Hanne.Beeckmans@kuleuven.be.
Pieterjan KerckhofLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Pieterjan.Kerckhof@kuleuven.be.
Gitte AertsLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Gitte.Aerts@kuleuven.be.
Celine AelbrechtLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Celine.Aelbrecht@kuleuven.be.
Janne VerhaegenLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Janne.Verhaegen@kuleuven.be.
Andrew HighamDivision of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Manchester University, UK. Electronic address: andrew.higham@manchester.ac.uk.
Walter CoudyzerDepartment of Radiology, UZ Leuven, Leuven, Belgium. Electronic address: walter.coudyzer@uzleuven.be.
Emanuela E CortesiLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Emanuelaelsa.Cortesi@kuleuven.be.
Arno VanstapelLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Arno.Vanstapel@kuleuven.be.
John E McDonoughFirestone Institute for Respiratory Health, St Joseph's Healthcare Hamilton, McMaster University, Hamilton, Canada. Electronic address: jmcdonough@mcmaster.ca.
Marianne S CarlonLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Marianne.Carlon@kuleuven.be.
Rozenn QuarckLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Rozenn.Quarck@kuleuven.be.
Matthieu N BooneDept of Physics and Astronomy, UGCT, Radiation Physics, Ghent University, Gent, Belgium. Electronic address: Matthieu.Boone@UGent.be.
Lieven DupontLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Lieven.dupont@uzleuven.be.
Stephanie EveraertsLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: stephanie.everaerts@uzleuven.be.
Dirk E Van RaemdonckLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: dirk.vanraemdonck@uzleuven.be.
Laurens J CeulemansLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium; Translational Cell and Tissue Research, KU Leuven and UZ Leuven, Leuven, Belgium. Electronic address: laurens.ceulemans@uzleuven.be.
Tillie-Louise HackettCenter for Heart Lung Innovation, The University of British Columbia, Vancouver, Canada. Electronic address: Tillie.Hackett@hli.ubc.ca.
Robin VosLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Robin.Vos@uzleuven.be.
Yasser AbuoufDepartment of Mechanical Engineer, Alexandria University, Egypt. Electronic address: yasser.abuouf@alexu.edu.eg.
Joseph JacobHawkes Institute, Department of Computer Science, UCL, London, UK; UCL Respiratory, UCL, London, UK. Electronic address: j.jacob@ucl.ac.uk.
Wim A WuytsLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Wim.Wuyts@uzleuven.be.
James C HoggCenter for Heart Lung Innovation, The University of British Columbia, Vancouver, Canada. Electronic address: Jim.Hogg@hli.ubc.ca.
Marcel FilochePhysique de la Matière Condensée, Ecole Polytechnique, Palaiseau, France. Electronic address: marcel.filoche@espci.psl.eu.
Ghislaine Gayan-RamirezLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Ghislaine.gayan-ramirez@kuleuven.be.
Wim JanssensLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: wim.janssens@uzleuven.be.
Bart M VanaudenaerdeLaboratory of Respiratory Diseases and Thoracic Surgery, BREATHE, Department of CHROMETA, KU Leuven, Leuven, Belgium. Electronic address: Bart.Vanaudenaerde@kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmall airways (<2 mm diameter) are major sites of airflow obstruction in chronic obstructive pulmonary disease (COPD). This study aimed to quantify the impact of small airway disease, characterized by narrowing, occlusion, and obliteration, on airflow parameters in smokers and end-stage patients with COPDs.

methodsWe performed computational fluid dynamics (CFD) simulations of inspiratory airflow in three lung groups: control non-used donor lungs (no smoking/emphysema history), non-used donor lungs with a smoking history and emphysema, and explanted end-stage COPD lungs. Each group included four lungs, with two tissue cylinders. Micro-CT-scanned small airways were segmented into 3D models for CFD simulations to quantify pressure, resistance, and shear stress. CFD results were benchmarked against simplified linear and Weibel models.

findingsCFD simulations showed higher pressures in COPD vs. controls (p = 0.0091) and smokers (p = 0.015), along with increased resistance (p = 0.0057 vs. controls; p = 0.0083 vs. smokers) and up to a tenfold rise in shear stress (p = 0.010 vs. controls). Narrowing and occlusion were shown to independently increase pressure, resistance, and shear stress, which were validated through segmentation corrections. Pressures and resistance assessed with simplified models were up to seven-fold higher for smokers and even 72 higher for COPD compared with CFD values.

interpretationThese findings show that increased airflow parameters can explain the association between small airway disease and airflow limitation in COPD, underscoring small airway vulnerability. Additionally, they highlight the limitations of theoretical models in accurately capturing small airway disease.

fundingSupported by the KU Leuven (C16/19/005).

Indexed as

HydrodynamicsPulmonary Disease, Chronic ObstructiveAgedComputer SimulationFemaleHumansLungMaleMiddle AgedModels, BiologicalSmokingX-Ray MicrotomographyAirway remodellingAirway resistanceChronic obstructive pulmonary disease (COPD)Computational fluid dynamics (CFD)ObstructionSmall airway disease

Identifiers

PMID40174553
PMCPMC11999283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.